Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 50

Investigating vancomycin's effects on multiple sclerosis

Official title: Impact of Vancomycin on the Gut Microbiome and Immune Function in Multiple Sclerosis

Run by Icahn School of Medicine at Mount Sinai · NCT05539729 · Data updated 2026-11-12

This study is testing if the antibiotic vancomycin can change gut bacteria and help improve symptoms in people who have just been diagnosed with multiple sclerosis.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment12 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 31, 2023
Main results expectedJune 2028
Study endsDecember 2028
Registry record updatedSeptember 28, 2026
Trial IDNCT05539729 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 50 who have been newly diagnosed with multiple sclerosis and are treatment naive.

Probably not a fit

Patients with a history of other autoimmune diseases or recent antibiotic use may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore how vancomycin influences the gut-brain axis in patients with multiple sclerosis (MS). It will assess the impact of vancomycin on gut microbiota composition, peripheral immune function, and brain MRI lesions in newly diagnosed MS patients. By understanding these mechanisms, the research seeks to clarify the role of gut microbes in neuroinflammation associated with MS. Participants will be randomly assigned to receive either vancomycin or a placebo.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic strategies for managing multiple sclerosis by targeting the gut microbiome.

How similar studies have gone: While the role of the gut microbiome in MS is being explored, this specific approach using vancomycin is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged 18 - 50
* newly diagnosed MS (2017 McDonald criteria), CIS or RIS patients, who have experienced symptoms no earlier than the past year
* treatment naive
* able to understand the risks, benefits, and alternatives of participation and give meaningful consent

Exclusion Criteria:

* antibiotic use within the past 90 days;
* pre- or probiotic use within past month or corticosteroids use within the past month;
* use of tobacco products within the past 1 month;
* history of treatment with immunosuppressants;
* history of gastroenteritis within the past month or diagnosis with a chronic infectious disease, i.e. hepatitis B, C or HIV;
* pregnancy or less than 6 months postpartum;
* irritable bowel syndrome and other bowel dysfunction such as constipation;
* history of bowel surgery;
* inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, diabetes and any other auto-immune illness;
* diagnosis with another neurological disease, behavioral or psychiatric conditions that would be incompatible with a safe and successful participation in the study (such as severe major depression, schizophrenia and presence of psychotic symptoms);
* eating disorders such as anorexia nervosa, bulimia, or binge eating syndrome;
* travel outside of the country within the past month;
* contraindication to vancomycin including estimated glomerular filtration rate of \<60ml/min, impaired hearing or known allergy.
* Contraindication to MRI such as implanted metallic objects

Where it's running

  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.